GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (FRA:8GN) » Definitions » Deferred Tax

Cessatech AS (FRA:8GN) Deferred Tax : €0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cessatech AS Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Cessatech AS's change in deferred tax for the three months ended in Sep. 2024 was €0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.

Cessatech AS Deferred Tax Historical Data

The historical data trend for Cessatech AS's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS Deferred Tax Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Deferred Tax
- 0.01 0.31 0.42

Cessatech AS Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cessatech AS Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cessatech AS Deferred Tax Related Terms

Thank you for viewing the detailed overview of Cessatech AS's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Cessatech AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (FRA:8GN) » Definitions » Deferred Tax
Comparable Companies
OSTO:ONCO OSTO:MVIR OSTO:ALZ XSAT:CURAS OSTO:ACE OSTO:ISOFOL OSTO:INIT OSTO:KDEV OSTO:LIPUM OSTO:XBRANE VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
CESSA:Sweden
Address
Kanonbadsvej 2, Copenhagen, DNK, 1437
Website
https://www.cessatech.com
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. Its product (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children. Its other products CT002 which is a Non-invasive nasal spray and CT003 which is a local anaesthetic gel are in different stages development.

Cessatech AS Headlines

No Headlines